Here, as a proof of concept, we use the recently described (Leung et al., 2016) protocol to obtain efficient neural crest induction and compare HipSci cell lines from healthy volunteers with two cell lines obtained from BBS patients carrying BBS10 mutations (Table 1). The gene discussed is BBS10; the disease is Bardet-Biedl syndrome.